Skip to main content
BrainCited

Lutein & Zeaxanthin Figure

17 figure da ricerca revisionata da esperti

Tutti Vitamin E Green Tea Extract (EGCG) Citicoline Folate Zinc Bacopa monnieri Omega-3 Fatty Acids (DHA/EPA) Alpha-Lipoic Acid Creatine Resveratrol Vitamin D L-Theanine Vitamin B12 Ginkgo biloba Lutein & Zeaxanthin Melatonin Rhodiola rosea Panax Ginseng Phosphatidylserine Taurine Curcumin Uridine Monophosphate
All Types Chart Diagram Photograph Flowchart Forest Plot Micrograph Other
Figure 2
Figure 2

Sustaining an ageing population: the role of micronutrients in frailty and cognitive …

Figure 6
Figure 6 Chart

Blood levels of DHA, EPA, and arachidonic acid are tracked over the intervention period, confirming adherence and bioavailability of the fatty acid supplement.

Effects of Long-Chain Polyunsaturated Fatty Acids in Combination with Lutein and Zeaxanthin …

Figure 7
Figure 7 Chart

Plasma lutein and zeaxanthin concentrations are compared between treatment and control groups, demonstrating successful supplementation and absorption.

Effects of Long-Chain Polyunsaturated Fatty Acids in Combination with Lutein and Zeaxanthin …

Figure 8
Figure 8 Chart

Macular pigment optical density measurements assess the accumulation of lutein and zeaxanthin in the retina following supplementation.

Effects of Long-Chain Polyunsaturated Fatty Acids in Combination with Lutein and Zeaxanthin …

Figure 9
Figure 9 Chart

Verbal memory test performance including word recall and recognition tasks is compared between supplementation and placebo groups.

Effects of Long-Chain Polyunsaturated Fatty Acids in Combination with Lutein and Zeaxanthin …

Figure 10
Figure 10 Chart

Visual memory and spatial recall scores are assessed following LCPUFA and lutein/zeaxanthin supplementation compared to placebo.

Effects of Long-Chain Polyunsaturated Fatty Acids in Combination with Lutein and Zeaxanthin …

Figure 11
Figure 11 Chart

Working memory and executive function task results are presented for both treatment arms, assessing broader cognitive effects of the combined supplementation.

Effects of Long-Chain Polyunsaturated Fatty Acids in Combination with Lutein and Zeaxanthin …

Figure 12
Figure 12 Chart

Processing speed assessments compare reaction time and cognitive throughput between the supplemented and placebo groups.

Effects of Long-Chain Polyunsaturated Fatty Acids in Combination with Lutein and Zeaxanthin …

Figure 13
Figure 13 Chart

Subgroup analyses stratify cognitive outcomes by baseline DHA status, revealing whether individuals with lower initial omega-3 levels benefit more from supplementation.

Effects of Long-Chain Polyunsaturated Fatty Acids in Combination with Lutein and Zeaxanthin …

Figure 14
Figure 14 Chart

Adverse event reporting and safety data demonstrate the tolerability of combined LCPUFA and carotenoid supplementation in older adults.

Effects of Long-Chain Polyunsaturated Fatty Acids in Combination with Lutein and Zeaxanthin …

Figure 15
Figure 15 Chart

Correlation analysis between blood fatty acid levels and episodic memory improvements explores dose-response relationships in the supplementation trial.

Effects of Long-Chain Polyunsaturated Fatty Acids in Combination with Lutein and Zeaxanthin …

Figure 16
Figure 16 Chart

Additional cognitive domain scores including attention and language fluency are compared between groups as secondary outcome measures.

Effects of Long-Chain Polyunsaturated Fatty Acids in Combination with Lutein and Zeaxanthin …

Figure 5. Combined analysis of the changes (∆-adjusted) in the scores of episodic memory function tests for subgroups with cognitive decline in Trials 1 and 2. (A) composite memory; (B), verbal memory; (C), visual memory. LCPUFAs, long-chain polyunsaturat
Figure 17 Chart

Combined analysis of episodic memory score changes in subgroups with low versus adequate baseline omega-3 status indicates differential treatment responses to LCPUFA supplementation with lutein and zeaxanthin.

Effects of Long-Chain Polyunsaturated Fatty Acids in Combination with Lutein and Zeaxanthin …

Figure 2
Figure 2 Diagram

Introductory overview of the carotenoid compounds evaluated for neuroprotective effects in Alzheimer's disease. The review examines how these dietary pigments may counteract neurodegeneration through antioxidant and anti-inflammatory pathways.

Carotenoid Supplementation for Alleviating the Symptoms of Alzheimer's Disease.

Figure 1. Alzheimer’s disease KEGG pathway (hsa05010; Alzheimer disease—Homo sapiens (human)) generated online at https://www.genome.jp/kegg-bin/show_pathway?hsa05010, accessed on 8 March 2024) [115].
Figure 3 Diagram

KEGG pathway map (hsa05010) illustrating the molecular cascade involved in Alzheimer's disease pathogenesis in humans. The diagram highlights potential intervention points where carotenoid compounds may modulate amyloid-beta accumulation, tau phosphorylation, and neuroinflammatory signaling.

Carotenoid Supplementation for Alleviating the Symptoms of Alzheimer's Disease.

Figure 7
Figure 7 Chart

Evidence summary on the association between specific carotenoid compounds and Alzheimer's disease biomarkers. The data suggest that higher carotenoid status may be linked to reduced oxidative damage in neural tissues.

Carotenoid Supplementation for Alleviating the Symptoms of Alzheimer's Disease.

α-,β-cryptoxanthin is a source of vitamin A due to the fact that it has an unsubstituted β ring, similar to α-, β-, and γ-carotene. In the body, it is enzymatically cleaved with the help of (BCO1) and (BCO2) to retinol, retinal, and retinoic acid, which i
Figure 22 Diagram

Alpha- and beta-cryptoxanthin serve as provitamin A sources due to their unsubstituted beta-ring structure. The review discusses their potential role in Alzheimer's disease prevention through both antioxidant activity and vitamin A metabolite production in neural tissue.

Carotenoid Supplementation for Alleviating the Symptoms of Alzheimer's Disease.